retatrutide 12mg Retatrutide, Experimental drug for obesity reducing 18% of adult weight Stock Photo retatrutide 12 mg vial Phase

Drug Discovery Today: Disease Mechanisms

Absolute contraindications include hypersensitivity to any component, severe hepatic failure, and sulfur-amino-acid disorders such as homocystinuria

The muscle loss problem explained GLP-1 agonist weight loss typically includes significant lean mass reduction

But how to tamp down those fires

Across studies investigating the impact of tirzepatide treatment on food- and appetite-related assessments (Table S1), tirzepatide treatment was generally associated with reduced overall fasting appetite, including reduced hunger, increased fullness, and reduced prospective food intake compared with placebo, liraglutide, and semaglutide